Inventor
ANLAI WANG
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
Y02ATechnologies for adaptation to climate change8%
PatentTitleYear
12,441,731Pyrazolopyrimidine compounds and uses thereof202512,384,778Pyrazolopyridine compounds and uses thereof202512,083,124Bicyclic heterocycles as FGFR inhibitors202411,795,166Pyrazolopyridine compounds and uses thereof202311,607,416Bicyclic heterocycles as FGFR inhibitors202311,591,329Bicyclic heterocycles as FGFR inhibitors202311,492,354Indazole compounds and uses thereof202211,229,631Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to INCYTE CORP (8)· patent assignee history
2022Patents assigned to INCYTE HOLDINGS CORP (1)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INCYTE CORP | 8 | 2022–2025 |
| INCYTE HOLDINGS CORP | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2025 |